Anti-TGF beta 1 antibody [EPR21143] and 2 more items

The University of Nebraska Medical Center (UNMC), located in Omaha, Nebraska, awarded a purchase order (PO) to Abcam Inc., a vendor based in Boston, Massachusetts. The contract, identified as 4800130497, encompasses the procurement of three specialized antibody research reagents with a total contract value of $1,620.00. The specific antibodies ordered include: Anti-MADH7/SMAD7 antibody (100mL) priced at $450.00, Anti-TGF beta 1 antibody [EPR21143] (100mL) priced at $535.00, and Anti-TGF beta 3 antibody [EPR27093-72] (100mL) priced at $635.00.

The contract's period of performance spans from July 30, 2025, to August 5, 2025, with delivery scheduled to UNMC Shipping and Receiving in Omaha, Nebraska. Payment terms are set at Net 30, and the transaction is tax-exempt under number 05-8905401. The purchase order is governed by the University of Nebraska's Standard Terms of Purchase, with F.O.B. destination and freight prepaid conditions. This transaction represents a targeted procurement of research-grade antibodies for scientific investigation, likely supporting ongoing medical or biological research initiatives at the University of Nebraska Medical Center.